Video Presentation: BD Innovations to Address the Unique Needs of Patients With Diabetes

AUGUST 31, 2017
Sponsored by BD.
BD is a partner to help you and your patients with diabetes. As the first company to develop and commercialize disposable syringes and short needle insulin syringes, Becton Dickinson (BD) continues to be a leader in diabetes innovation and care.1,2
Over the past several years, BD innovations have helped improve the safety and comfort of administering injections in patients with diabetes. BD innovations include specialized products that reduce the risk of accidental intramuscular injection, accidental needle sticks, and dosing errors with concentrated insulin.2-5

In this video presentation featuring Mary Bridgeman, PharmD, BCPS, BCGP, you will learn how BD innovations can help your patients with diabetes.

  1. Fry A. Insulin delivery device technology 2012: where are we after 90 years? J Diabetes Sci Technol. 2012;6(4):947-953. doi: 10.1177/193229681200600428.
  2. BD receives FDA clearance for new syringe designed for the administration of Humulin R U-500 insulin [news release]. Franklin Lakes, NJ: Becton Dickinson and Company; August 15, 2016. . Accessed January 19, 2017.
  3. Frid AH, Kreugel G, Grassi G, et al. New insulin delivery recommendations. Mayo Clin Proc. 2016;91(9):1231-1255. doi: 10.1016/j.mayocp.2016.06.010.
  4. Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin. 2010;26(6):1519-1530. doi: 10.1185/03007995.2010.481203.
  5. Ruan T, Richards S, Zaiken E, Newman C, Goykhman V, Alu J, Quinn V, inventors; Becton, Dickinson and Company, assignee. Safety pen needle assembly having shielding for patient and non-patient ends. US patent 8,652,503. January 21, 2014.  . Accessed January 19, 2017.